← board
CPHI
distress 6/10 · elevated risk$1.83+7%today-77% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
—
Shares 1y
+1142%
Price & events
+45.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+7.0%
1D
+48.8%
1W
+161.5%
1M
+210.2%
3M
+47.6%
6M
+0.6%
1Y
-29.6%
2Y
-99.5%
5Y
-99.3%
All
Overview
- Market Cap
- $74.16M
- Volume
- 5.76M
- 52 Week Range
- $0.52 – $8.10
- Total Shares
- 40.52M
- Float Shares
- 800.72K
- Short %
- 0.09%
- % Held by Insiders
- 95.16%
- % Held by Institutions
- 0.06%
- RVOL
- 0.70x
- Beta
- 1.15
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.